May 15, 2020
SUZHOU, China, and ROCKVILLE, Md., May 15, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the latest...
Source URL: https://www.prnewswire.com:443/news-releases/ascentage-pharma-to-present-six-abstracts-at-2020-aacr-annual-meeting-301060006.html
|
